Classical RB is initiated by biallelic inactivation of the tumor suppressor gene RB1 and identified in most RB cases, whereas novel subtype of RB is initiated by high focal MYCN amplification and accounts for < 2% of all cases [20, 21]. Here, MYCN is linked to retinoblastoma.